Pankti Reid to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Pankti Reid has written about Dose-Response Relationship, Drug.
Connection Strength
0.171
-
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
Score: 0.138
-
Applied Clinical Pharmacology in a Crisis: Interleukin-6 Axis Blockade and COVID-19. Clin Pharmacol Ther. 2020 09; 108(3):425-427.
Score: 0.033